ArticleHematology reports2020

Efficacy and safety of biosimilar rituximab (ZytuxTM) in newly diagnosed patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Alaa Fadhil Alwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.